Vascular Surgery, University of Bologna, DIMEC, Bologna, Italy.
Vascular surgery unit, IRCCS Azienda Ospedaliero-universitaria di Bologna, Bologna, Italy.
Eur J Cardiothorac Surg. 2024 Nov 4;66(5). doi: 10.1093/ejcts/ezae387.
Aim of the study was to analyse the impact of preoperative thoracoabdominal aneurysm diameter on the outcomes of fenestrated/branched endografting.
Patients who underwent endovascular thoracoabdominal repair at 2 European centres (2011-2021) were analysed. Median diameter was calculated; the third quartile was considered a cut-off. Outcomes were compared in 2 groups based on the diameter value. Primary endpoints were technical success, spinal cord ischaemia and 30-day/in-hospital mortality. Survival, freedom from reintervention and target visceral vessels instability were follow-up outcomes.
Out of 247 thoracoabdominal aortic aneurysms, the median diameter was 65 mm, first quartile was 57 mm; third quartile was 80 mm, set as cut-off value. Fifty-nine (24%) patients had diameter ≥80 mm. Custom-made and off-the-shelf branched endograft were used in 160 (65%) and 87 (35%), respectively. Technical success was 93% (<80 mm: 91% vs ≥80 mm: 94%; P = 0.47). Twenty-three (9%) patients had spinal injury (<80 mm: 7% vs ≥80mm: 17%; P = 0.03). Twenty-two (9%) patients died within 30-day/in-hospital (<80 mm: 7% vs ≥80 mm: 15%; P = 0.06). Multivariate analysis did not report preoperative diameter ≥80 mm as significant risk factor for primary endpoints. The median follow-up was 13 (interquartile range: 2-37) months and at 3-year survival and freedom from reintervention rates were 65% and 62%, respectively. After univariate and multivariate analyses, preoperative diameter ≥80 mm was considered an independent risk factor for reinterventions [hazard ratio (HR): 1.9; 95% confidence interval (CI) 1.1-3.6; P = 0.04], and for target visceral vessels instability (HR: 3.1; 95% CI: 1.3-5.1; P = 0.04), occurred in 45 (18%) cases. However, after competing risk methods, preoperative diameter did not show significance for follow-up results.
A preoperative thoracoabdominal aortic aneurysm diameter >80 mm has not had a direct impact on early technical and clinical outcomes. A diameter≥80 mm is considered risk factor for reinterventions and target vessels instability is considered separately during follow-up.
本研究旨在分析术前胸腹主动脉瘤直径对腔内分支型胸腹主动脉瘤修复术治疗结局的影响。
对欧洲 2 家中心(2011 年至 2021 年)接受腔内胸腹主动脉修复术的患者进行分析。计算中位数直径;将第三四分位数视为截止值。根据直径值将两组患者的结果进行比较。主要终点为技术成功、脊髓缺血和 30 天/住院死亡率。随访结果包括生存率、免于再次干预和目标内脏血管不稳定。
在 247 例胸腹主动脉瘤患者中,中位数直径为 65mm,第 1 四分位数为 57mm,第 3 四分位数为 80mm,设为截止值。59 例(24%)患者的直径≥80mm。160 例(65%)和 87 例(35%)患者分别使用定制型和现货型分支型覆膜支架。技术成功率为 93%(直径<80mm:91% vs 直径≥80mm:94%;P=0.47)。23 例(9%)患者发生脊髓损伤(直径<80mm:7% vs 直径≥80mm:17%;P=0.03)。22 例(9%)患者在 30 天/住院期间死亡(直径<80mm:7% vs 直径≥80mm:15%;P=0.06)。多因素分析未报告术前直径≥80mm 是主要终点的显著危险因素。中位随访时间为 13 个月(四分位距:2-37),3 年生存率和免于再次干预率分别为 65%和 62%。单因素和多因素分析后,术前直径≥80mm 被认为是再次干预的独立危险因素[风险比(HR):1.9;95%置信区间(CI):1.1-3.6;P=0.04],也是目标内脏血管不稳定的独立危险因素(HR:3.1;95%CI:1.3-5.1;P=0.04),共 45 例(18%)发生。然而,在竞争风险方法后,术前直径对随访结果无显著影响。
术前胸腹主动脉瘤直径>80mm 并未对早期技术和临床结局产生直接影响。直径≥80mm 被认为是再次干预和目标血管不稳定的危险因素,在随访期间需要分别考虑。